cobalt has been researched along with marimastat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cullinane, C; Diakos, CI; Failes, TW; Hambley, TW; Lyons, JG; Yamamoto, N | 1 |
Glenister, A; Green, BP; Hambley, TW; Renfrew, AK; Turner, P | 1 |
2 other study(ies) available for cobalt and marimastat
Article | Year |
---|---|
Studies of a cobalt(III) complex of the MMP inhibitor marimastat: a potential hypoxia-activated prodrug.
Topics: Amines; Animals; Antineoplastic Agents; Cobalt; Electrochemistry; Enzyme Inhibitors; Hydroxamic Acids; Hypoxia; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase Inhibitors; Mice; Organometallic Compounds; Prodrugs; Pyridines; Time Factors; Tumor Cells, Cultured; X-Ray Diffraction | 2007 |
The influence of the ancillary ligand on the potential of cobalt(iii) complexes to act as chaperones for hydroxamic acid-based drugs.
Topics: Cell Line, Tumor; Cell Survival; Cobalt; Coordination Complexes; Crystallography, X-Ray; Cyclams; Electrochemical Techniques; Heterocyclic Compounds; Humans; Hydroxamic Acids; Kinetics; Ligands; Microscopy, Confocal; Molecular Chaperones; Molecular Conformation; Oxidation-Reduction; Spectrometry, Fluorescence | 2017 |